Salica Investments led a $21m funding round in Outcomes4Me.

Salica Investments, an investment firm, led a $21m funding round in Outcomes4Me, a developer of the leading direct-to-patient, AI-driven platform transforming the cancer care experience, with participation from Labcorp Venture Fund, Forecast Labs, Northpond Ventures, Sierra Ventures, Asset Management Ventures, IRA Capital, and Merstal LTD. "AI will reshape cancer care, and this investment accelerates our ability to deliver personalized treatments and improved outcomes to patients at scale.With more than 280,000 cancer patients using our AI-enabled platform, we're not just offering people diagnosed with cancer a tool, we're empowering them with intelligent, real-time insights that guide them through every step of their care. This funding will help us further enhance our platform, expand our reach, and drive meaningful revenue growth," Maya R. Said, Outcomes4Me Founder and CEO.